S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
His system isolated NVIDIA - Here's His Next Buy. (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
His system isolated NVIDIA - Here's His Next Buy. (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
His system isolated NVIDIA - Here's His Next Buy. (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
His system isolated NVIDIA - Here's His Next Buy. (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
NASDAQ:OABI

OmniAb (OABI) Stock Forecast, Price & News

$5.19
-0.09 (-1.70%)
(As of 09/29/2023 ET)
Compare
Today's Range
$5.11
$5.34
50-Day Range
$4.98
$5.93
52-Week Range
$1.91
$10.50
Volume
925,152 shs
Average Volume
362,956 shs
Market Capitalization
$602.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

OmniAb MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
92.7% Upside
$10.00 Price Target
Short Interest
Bearish
4.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.65mentions of OmniAb in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$246,600 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.45) to ($0.44) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

528th out of 969 stocks

Commercial Physical Research Industry

9th out of 14 stocks


OABI stock logo

About OmniAb (NASDAQ:OABI) Stock

OmniAb, Inc., a biotechnology company, engages in the provision of therapeutic antibody discovery technologies in the United States. The company's discovery platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTau, which features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

OABI Price History

OABI Stock News Headlines

Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
OmniAb: Hold For Growth
OABIW OmniAb, Inc. WT EXP 110127
OmniAb President Acquires 2.0% More Stock
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Truist Financial Remains a Buy on OmniAb (OABI)
OmniAb Announces the Passing of Director Sunil Patel
OmniAb: Plenty Of Potential
OmniAb (OABI) Investor Presentation - Slideshow
OmniAb: 6 Months In And Going Strong
SVB Securities Remains a Buy on OmniAb (OABI)
See More Headlines
Receive OABI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter.

OABI Company Calendar

Last Earnings
8/10/2023
Today
9/30/2023
Next Earnings (Estimated)
11/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OABI
Fax
N/A
Employees
95
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$13.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+92.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Net Income
$-22,330,000.00
Pretax Margin
-51.62%

Debt

Sales & Book Value

Annual Sales
$59.08 million
Book Value
$2.96 per share

Miscellaneous

Free Float
108,036,000
Market Cap
$602.92 million
Optionable
Not Optionable
Beta
-0.55
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Matthew W. Foehr (Age 50)
    Pres, CEO & Director
    Comp: $967.72k
  • Mr. Kurt A. Gustafson (Age 55)
    Exec. VP of Fin. & CFO
    Comp: $558.48k
  • Mr. Charles S. Berkman J.D. (Age 54)
    Chief Legal Officer & Sec.
    Comp: $734.33k
  • Ms. Cia McCaffrey
    VP of People & Talent
  • Dr. Bill Harriman Ph.D.
    Sr. VP of Antibody Discovery
  • Ms. Marie-Cecile van de Lavoir D.V.M.
    Ph.D., Sr. VP of Technical Operations & Genetics
  • Dr. Christel Iffland Ph.D.
    Sr. VP of Antibody Technologies
  • Dr. Douglas S. Krafte Ph.D. (Age 65)
    Sr. VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
  • Ms. Donna Ventura CPA
    Sr. VP of Corp. Controller













OABI Stock - Frequently Asked Questions

Should I buy or sell OmniAb stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OmniAb in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OABI shares.
View OABI analyst ratings
or view top-rated stocks.

What is OmniAb's stock price forecast for 2023?

9 Wall Street research analysts have issued 1 year target prices for OmniAb's stock. Their OABI share price forecasts range from $6.00 to $13.00. On average, they anticipate the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price.
View analysts price targets for OABI
or view top-rated stocks among Wall Street analysts.

How have OABI shares performed in 2023?

OmniAb's stock was trading at $3.60 at the beginning of the year. Since then, OABI shares have increased by 44.2% and is now trading at $5.19.
View the best growth stocks for 2023 here
.

When is OmniAb's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
View our OABI earnings forecast
.

How were OmniAb's earnings last quarter?

OmniAb, Inc. (NASDAQ:OABI) released its quarterly earnings results on Thursday, August, 10th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.04. The firm had revenue of $6.95 million for the quarter, compared to the consensus estimate of $13.05 million.

What is OmniAb's stock symbol?

OmniAb trades on the NASDAQ under the ticker symbol "OABI."

How do I buy shares of OmniAb?

Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OmniAb's stock price today?

One share of OABI stock can currently be purchased for approximately $5.19.

How much money does OmniAb make?

OmniAb (NASDAQ:OABI) has a market capitalization of $602.92 million and generates $59.08 million in revenue each year. The company earns $-22,330,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.

How can I contact OmniAb?

OmniAb's mailing address is 65 EAST 55TH STREET 18TH FLOOR, NEW YORK NY, 10022. The official website for the company is www.omniab.com. The company can be reached via phone at 510-250-7800 or via email at investors@omniab.com.

This page (NASDAQ:OABI) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -